MyndTec Announces Exclusive License Agreement with Albany Medical College for AI-Based Spinal Cord Stimulation Technology
November 11, 2024

Mississauga, Ontario, November 11, 2024 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), a medical technology company focused on neurological treatment, rehabilitation and regeneration,...

MyndTec Inc. Completes First Tranche of Non-Brokered Private Placement
October 23, 2024

Mississauga, Ontario, October 23, 2024 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), a neurological treatment and rehabilitation medical technology company, is pleased to...

Correction to Press Release Issued October 1, 2024 Regarding Non-Brokered Private Placement
October 7, 2024

Mississauga, Ontario, October 7, 2024 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), announced today a correction to its press release titled “MyndTec Inc....

MyndTec Inc. Announces Non-Brokered Private Placement
October 1, 2024

Mississauga, Ontario, October 1, 2024 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), an emerging player in neurological treatment and rehabilitation, is pleased to...

MyndTec Inc. Completes Seventh Tranche of Non-Brokered Private Placement
August 12, 2024

Mississauga, Ontario, August 12, 2024 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), an emerging player in neurological treatment and rehabilitation, is pleased to...

MyndTec Inc. Announces the MyndMove System’s Showcase at the Dearborn 2024 Para Dance Sport International Competition & USA Open and Celebrates the Updated Health Canada License for the MyndMove System to Treat Lower Limb
August 7, 2024

Mississauga, Ontario, August 7, 2024 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), an emerging player in neurological treatment and rehabilitation, is proud to...

MyndTec Inc. Completes Sixth Tranche of Non-Brokered Private Placement
June 24, 2024

Mississauga, Ontario, June 24, 2024– MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), an emerging player in neurological treatment and rehabilitation, is pleased to announce...

MyndTec Inc. Completes Fifth Tranche of Non-Brokered Private Placement
May 27, 2024

Mississauga, Ontario, May 27, 2024 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC) an emerging player in neurological treatment and rehabilitation, is pleased to...

MyndTec Announces License Agreement with University of Toronto for Neuroregeneration Technology
May 23, 2024

Mississauga, Ontario, May 23, 2024 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), a medical technology company focused on neurological treatment, rehabilitation and regeneration,...

MyndTec Brain Activity Technology Licensed from UHN Awarded U.S. Patent
April 9, 2024

Mississauga, Ontario, April 9, 2024 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), an emerging player in neurological treatment and rehabilitation, today announced that...

MyndTec Inc. Completes Fourth Tranche of Non-Brokered Private Placement
March 19, 2024

Mississauga, Ontario, March 19, 2024 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), an emerging player in neurological treatment and rehabilitation, is pleased to...

MyndTec Inc. Completes Third Tranche of Non-Brokered Private Placement
February 13, 2024

Mississauga, Ontario, February 13, 2024 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), an emerging player in neurological treatment and rehabilitation, is pleased to...

MyndTec Inc. Receives Statement of Claim and Intends to Defend Itself
January 22, 2024

Mississauga, Ontario, January 22, 2024 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), a medical technology company, today announced it has been served with...

MyndTec Inc. Completes Second Tranche of Non-Brokered Private Placement
December 20, 2023

Mississauga, Ontario, December 20, 2023 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), an emerging leader in neurological treatment and rehabilitation, is pleased to...

MyndTec Inc. Completes Non-Brokered Private Placement
November 3, 2023

Mississauga, Ontario, November 3, 2023 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), an emerging leader in neurological treatment and rehabilitation, is pleased to...

MyndTec Inc. Announces Non-Brokered Private Placement
October 13, 2023

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. Mississauga, Ontario, October 13, 2023 – MyndTec Inc. (“MyndTec” or the...

MyndTec Inc. Announces Debt Settlement Agreement with a Director
August 17, 2023

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. Mississauga, Ontario, August 17, 2023 – MyndTec Inc. (“MyndTec” or the...

MyndTec Inc. Closes Previously Announced Shares for Debt Transaction
July 13, 2023

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. Mississauga, Ontario, July 13, 2023 – MyndTec Inc. (“MyndTec” or the...

MyndTec Inc. Announces Debt Settlement Agreement
July 6, 2023

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. Mississauga, Ontario, July 6, 2023 – MyndTec Inc. (“MyndTec” or the...

MyndTec Inc. Announces Strategic Consulting Agreement with Rehabilitation Technology Industry Expert
May 30, 2023

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. Mississauga, Ontario, May 30, 2023 – MyndTec Inc. (“MyndTec” or the...

MyndTec Inc. Announces Grant of Stock Options In Connection with A Consulting Agreement
May 26, 2023

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. Mississauga, Ontario, May 26, 2023 – MyndTec Inc. (“MyndTec” or the...

MyndTec Inc. Completes Non-Brokered Private Placement
May 25, 2023

Not for distribution to U.S. news wire services or dissemination in the United States Mississauga, Ontario, May 25, 2023 – MyndTec Inc. (“MyndTec” or the...

MyndTec Inc. Announces Non-Brokered Private Placement
March 22, 2023

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. Mississauga, Ontario, March 22, 2023 – MyndTec Inc. (“MyndTec” or the...

MyndTec Inc. Completes Non-Brokered Private Placement
January 11, 2023

Not for distribution to U.S. news wire services or dissemination in the United States. Mississauga, Ontario, January 11, 2023 – MyndTec Inc. (“MyndTec” or the...

MyndTec Inc. Announces Non-Brokered Private Placement
November 9, 2022

Mississauga, Ontario, November 9, 2022, – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), an emerging leader in neurological treatment and rehabilitation, is pleased to...

MyndTec Announces the North American Launch of its Innovative Foot Drop FES Device MyndStep™
November 2, 2022

MyndStep™ is designed to improve mobility by providing functional electrical stimulation (FES) treatment to patients suffering from foot drop. Mississauga, Ontario, November 2, 2022, –...

MyndTec Announces Exclusive Supply and Distribution Agreement for Innovative Foot Drop FES Device MyndStep™ across the US and Canada
August 5, 2022

MyndStep™ is designed to provide functional electric stimulation (FES) treatment to patients suffering from foot drop and improve walking ability. Highlights: MyndTec expands its FES...

MyndTec Announces Board Changes
May 11, 2022

William (Bill) Jackson, a well-rounded medical device and healthcare entrepreneur joins MyndTec’s Board of Directors Mississauga, Ontario, May 11, 2022 – MyndTec Inc. (“MyndTec” or...

MyndTec Announces Investor Relations Agreement with Venture North Capital
May 3, 2022

Mississauga, Ontario, May 3, 2022 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), an emerging leader in neurological rehabilitation, is pleased to announce that...

Fourier Intelligence Inks Strategic Alliance Partnership with MyndTec Inc.
March 22, 2022

The award-winning Canadian MyndMove™ therapy from MyndTec. Inc joins SoftBankbacked rehab robotics leader Fourier Intelligence’s network of partners SINGAPORE, March 22nd, 2022 – Fourier Intelligence...

MyndTec Announces Resignation of Director
March 8, 2022

Mississauga, Ontario, March 8, 2022 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), an emerging trailblazer in neurological rehabilitation, today announced that Christine Ozimek...

MyndTec Receives FDA 510(k) Clearance for MyndMove 2.0, its Second Generation Neuromodulation Device, for Clinical and Home Use
March 8, 2022

Mississauga, Ontario, March 8, 2022 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), an emerging trailblazer in neurological rehabilitation, today announced that it has...

Ownership of Milos and Kathrin Popovic in MyndTec Inc.
February 24, 2022

Toronto, Canada – February 24, 2022 – MyndTec Inc. (MyndTec or Company) filed and received a receipt for its final non-offering prospectus (the Prospectus) from...

Ownership of James Anderson in MyndTec Inc.
February 24, 2022

Toronto, Canada – February 24, 2022 – MyndTec Inc. (MyndTec or the Company) filed and received a receipt for its final prospectus (the Prospectus) from...

MYNDTEC INC. ANNOUNCES CLOSING OF DISTRIBUTION OF SECURITIES ISSUABLE UPON CONVERSION OF SUBSCRIPTION RECEIPTS AND LISTING ON CSE
February 24, 2022

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. MISSISSAUGA, ONTARIO February 24, 2022 — MyndTec Inc. (“MyndTec” or the...

Ownership of Peter Harvey Griggs in MyndTec Inc.
February 24, 2022

Toronto, Canada – February 24, 2022 – MyndTec Inc. (MyndTec or the Company) filed and received a receipt for its final non-offering prospectus (the Prospectus)...

MyndTec Inc. Files Final Prospectus and Receives Conditional Listing Approval from the Canadian Securities Exchange
February 16, 2022

Mississauga, Ontario (Newsfile Corp. – February 16, 2022) – MyndTec Inc. (“MyndTec” or the “Company”) is pleased to announce that it has filed and received...